For capsule products, brands should calculate capsule count early
Your small intestine adds trypsin, chymotrypsin, and other proteases that further break down peptide chains
In phase 2 trials, participants achieved up to a 24.2% reduction in body weight over 48 weeks, surpassing results from existing GLP-1 or dual agonist therapies
(PubMed) Myint PK, Luben RN, Welch AA, Bingham SA, Wareham NJ, Khaw KT
Debated Unsettled Safety Issues Cancer Concerns about a possible connection between GLP-1 RAs and the development of neoplasms have spurred several investigations, especially on thyroid and pancreatic cancers due to a plausible mechanism and a large number of reports in the post-marketing phase [118, 128, 130]
References: Semeco A